Tomonori Ishii
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 157 publications
Successful treatment of refractory hemophagocytic lymphohistiocytosis complicating Epstein-Barr virus-positive classic Hodgkin lymphoma with rituximab.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: August 30, 2026
Updated 2026 Japanese Diagnostic Criteria for Takayasu Arteritis.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: August 26, 2026
Achievement of intermediate treatment targets for Still's disease under tocilizumab treatment: a post-hoc analysis of the phase III trial.
Journal: Immunological medicine
Published: June 26, 2026
JCS 2026 Guideline on Management of Large Vessel Vasculitis.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: March 22, 2026
Clinical outcomes of upadacitinib continuation vs withdrawal in giant cell arteritis through 2 years.
Journal: Annals of the rheumatic diseases
Published: March 14, 2026
Extramedullary Hematopoiesis Showing Lymphadenopathy in Myelodysplastic Syndrome without Myelofibrosis.
Journal: Internal medicine (Tokyo, Japan)
Published: February 18, 2026
Rapid versus conventional glucocorticoid tapering in pure membranous LN: a multicentre retrospective study.
Journal: Rheumatology advances in practice
Published: January 15, 2026
Thrombotic microangiopathy in a patient with anti-signal recognition particle antibody-positive immune-mediated necrotising myopathy: a case report.
Journal: Modern rheumatology case reports
Published: December 12, 2025
Primary large B-cell lymphoma of the central nervous system mimicking inflammatory myelitis at initial presentation.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: November 30, 2025
Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity: a randomised, controlled trial (SORAIRO trial).
Journal: Annals of the rheumatic diseases
Published: November 10, 2025
Strong inhibition of IL-6 signal is clinically and serologically effective in refractory adult-onset Still's disease.
Journal: Rheumatology (Oxford, England)
Published: October 07, 2025
Last Updated: 09/26/2026